This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
The study sample was not determined in the planning phase. In addition, no power calculations were conducted retrospectively. Consecutive patients who visited primary care practices between April 1996 and September 1997 were asked to complete a 2-stage screening test for depression. Initially, 653 of the 11,006 people screened were found to be positive and met the study inclusion criteria for enrolment. Of these 653 patients, 174 (26.6%) refused further evaluation. Overall, of the 479 positively screened patients who agreed to be evaluated further, 268 (124 in the enhanced care group and 144 in the usual care group) were excluded because they had been recently treated. Thus, there were 211 participants in the study, 115 in the enhanced care group and 96 in the usual care group.
The study participants were, on average, aged 43.1 years (standard deviation 14.8), 84.4% were female and 15.6% belonged to minority groups. In addition, 47.4% were currently married, 79.2% had a high school education, 62.1% were employed either full-time or part-time, and 82.5% were insured for health care. The patients had an average of 2.1 physical co-morbidities, and they reported an average of 6.4 DSM-III-R depression criteria during the previous 2 weeks. Ten per cent of the patients met dysthymia criteria in the previous year and 73.3% reported a prior incident of depression.
Study design
The analysis was based on a multi-centre (12 primary care practices) randomised controlled trial. Using blockrandomisation, the 12 primary care practices were stratified according to baseline pattern characteristics and were matched into 6 blocks according to depression treatment patterns. One practice from each block was randomly assigned to enhanced care. The patients were followed up at 6, 12, 18 and 24 months, through a structured telephone interview conducted by an independent research interviewer blinded to the intervention. Only in 3 cases was the interviewer aware of the type of intervention. The authors reported that the overall response rate was 89.6% at 6 months, 81.5% at 12 months, 72.5% at 18 months and 67.3% at 24 months. In the enhanced care group, 15.6% of the patients were lost to follow-up at 6 months and 40% at 24 months. In the usual care group, 4% of the patients were lost to follow-up at 6 months and 24% at 24 months. The reasons for withdrawals were not provided.
Analysis of effectiveness
The analysis was conducted on an intention to treat basis. The primary outcome was the number of days free of depression during the past 4 weeks. Therefore, the patients were asked to report the number of days in the past 4 weeks during which their emotional problems kept them in bed for the whole or most of the day, or they were unable to perform their usual activities for 1 half-day or more. The authors reported that the patients in the enhanced and usual care groups were comparable in most of their baseline characteristics. The two groups differed significantly in age, depression severity and physical co-morbidity, although appropriate adjustments were carried out for potential confounding factors.
The measure of benefits used was the quality-adjusted life-years (QALYs). Most of the utility values were derived from the literature.
For further details on the methods employed to value different health states, the reader is referred to the appendix of the current study and to the Annals of Family Medicine website at the following url: http://www.annfammed.org/cgi/content/full/3/1/7/DC1)
Direct costs
The categories of costs included were programme costs, outpatient costs, and patient time and transportation. The programme costs covered the time costs of professionals (salary plus fringe) for screening, preparation and delivery of enhanced care, record keeping and review, and care manager-physician communication, and overheads. Outpatient costs covered primary care visits, specialty mental health care visits, emergency department visits and psychotropic medications. Patient time and transportation covered the cost of travel time, and clinic and waiting time for employed patients.
For unemployed patients, the authors used average wage rates for the fiscal year 2000 by gender and education to proxy time costs. The costs and the quantities were only reported separately for programme costs. Resource use associated with the programme was derived from care management logs, while the equivalent costs were obtained from Bureau of Labor Statistics. The remaining resources used were based on patient-reported utilisation. Most of the costs were derived from official published sources. Only the source of transportation costs was not reported. Inpatient costs, productivity costs and non-psychotropic medication costs were excluded from the analysis and a justification for their exclusion was provided. All the costs were appropriately adjusted using the Consumer Price Index and were reported for the price year 2000. Discounting was irrelevant, as the costs were incurred during 2 years, and was omitted.
